Status:

UNKNOWN

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Lead Sponsor:

MTmedical Institute of Health

Collaborating Sponsors:

The University of Texas Health Science Center at San Antonio

BioMonde Preparations Limited

Conditions:

Chronic Hepatitis C

Chronic Hepatitis B

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Open-label studies, anecdotal reports, and in vitro scientific research indicate that 4-methylumbelliferone (active ingredient of the dietary supplement Heparvit®) may prevent and reverse the symptoms...

Detailed Description

(i). Chronic hepatitis B Chronicity of HBV following acute infection is strongly age-related; the majority (90%) of infants acquiring HBV perinatally go on to develop chronic infection, while most pe...

Eligibility Criteria

Inclusion

  • Serum ALT at least 1.5x the upper limit of normal
  • For chronic HBV: Known positive serum HBeAg for at least 6 months; Presence of HBV DNA in serum
  • For chronic HCV: Presence of anti-HCV in serum within 6 months of enrollment; Positive serum HCV RNA (enrollment)
  • Written informed consent

Exclusion

  • Treatment (within past 3 months) with interferon, ribavirin, lamivudine, entecavir, or adefovir dipivoxil
  • Current treatment with any drug or dietary supplement that could affect serum transaminase values (e.g., milk thistle)
  • Pregnancy or inability to practice contraception in patients capable of bearing or fathering children
  • Decompensated liver disease (as indicated by total bilirubin \>4 mg/dL; albumin \<3 g/dL; prolonged (\>2 sec over control) prothrombin time; or history of bleeding esophageal varices, ascites or hepatic encephalopathy)
  • Active alcohol use, drug abuse, and/or psychiatric problems that, in the investigator's opinion, could interfere with participation in the study
  • Hepatitis D infection (for HBV-infected patients)

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

End Date :

August 1 2007

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00225537

Start Date

September 1 2005

End Date

August 1 2007

Last Update

September 11 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Center Downtown "Brady/Green", 527 North Leona,

San Antonio, Texas, United States, 78207